SCHEMBL19200767

SCHEMBL19200767

COc1ccc(/C(=C(/CCNC(=O)C(=O)N2CCOCC2)c2ccc(-c3cccc(/C(=C(\CCNC(=O)C(=O)N4CCCCC4)c4ccc(-c5ccc(/C(=C(\CCNC(=S)N6CCCC6)c6ccccc6)c6ccc(OC)cc6)cc5)cc4)c4ccc(OC)cc4)c3)cc2)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ ALDH1A1 P00352 5/20 0.40
▸ HPGD P15428 2/20 0.40
▸ ALOX5 P09917 1/20 0.40
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ HTT P42858 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MAPT P10636 4/20 0.40
▸ GAA P10253 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ ERCC5 P28715 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ CTSL P07711 1/20 0.38
▸ CTSS P25774 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17505994 0.86 SMN1; SMN2 (0.47) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL17505992 0.86 SMN1; SMN2 (0.47) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL17505998 0.83 ALDH1A1 (0.47) MEN1KMT2AALDH1A1HPGDALOX5
SCHEMBL19181382 0.83 ALDH1A1 (0.47) MEN1KMT2AALDH1A1HPGDALOX5
SCHEMBL19182066 0.83 ALDH1A1 (0.47) MEN1KMT2AALDH1A1HPGDALOX5
SCHEMBL17506006 0.83 ALDH1A1 (0.47) MEN1KMT2AALDH1A1HPGDALOX5
SCHEMBL17524123 0.82 ALDH1A1 (0.52) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL17524122 0.82 ALDH1A1 (0.52) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL17506004 0.77 BLM (0.51) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL17506002 0.77 BLM (0.51) RAB9AMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170217914-A1 Novel Triarylethylene Compounds and Methods Using Same THE PENN STATE RESEARCH FOUNDATION 2017-08-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217914-A1 Novel Triarylethylene Compounds and Methods Using Same CYP46A1, GSTA2, GSTA1 RAB9A 2537/4885MEN1 976/4885KMT2A 864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback